MOTS-c peptide research
Peptide Therapy in Pasadena

MOTS-c

Explore mitochondrial and metabolic research with personalized medical guidance.

Book Your Appointment

What Is MOTS-c?

MOTS-c is a 16-amino-acid peptide derived from mitochondrial DNA. Scientists study its role in cellular energy signaling and responses to metabolic stress.

Mitochondrial peptide research illustration

Emerging research: MOTS-c is investigational and not FDA-approved. Naturally occurring signaling and experimental treatment are different questions; clinical benefits and long-term safety remain uncertain.

Why Mitochondrial Signaling Matters

Mitochondria produce energy and communicate with the rest of the cell. MOTS-c research explores how those signals relate to changing energy demands.

Man wearing a continuous glucose monitor reviewing health information with a clinician

Energy Sensing

Preclinical studies examine AMPK, a pathway involved in sensing cellular energy availability and coordinating metabolic responses.

Cellular Adaptation

Research explores communication between mitochondria and the nucleus during metabolic stress. These mechanisms do not by themselves establish a clinical treatment.

Current Areas of Research

The science spans laboratory models, animal experiments, and human observations. Each type of evidence answers a different question.

Metabolic Health

Experimental work examines glucose use and insulin-sensitivity pathways. It does not establish MOTS-c as a treatment for diabetes or a substitute for prescribed care.

Exercise and Skeletal Muscle

Human research has measured naturally occurring MOTS-c around exercise. This does not show that administering it reproduces the benefits of physical activity.

Metabolic Flexibility

Researchers explore how cells adapt to different fuel sources and energy demands. Clinical improvements in energy or weight cannot be assumed.

Healthy Aging

Mitochondrial function changes with age, making these signals a research interest. Claims of reversing aging or extending human life are not established.

Human Research: What Is Being Tested?

The MOTS-MET study record describes a Phase 2a, placebo-controlled trial in adults with prediabetes and overweight or obesity.

Black woman presenting a mitochondria research illustration

A Study in Progress, Not a Proven Outcome

The record describes assessments of insulin sensitivity and safety. No results were posted when reviewed on September 9, 2026. Registration does not mean FDA approval or confirmation that the intervention works.

View the MOTS-MET study record

Safety and Treatment Questions

Repeated-use safety, interactions, and a validated clinical regimen have not been established.

Medical provider in a clinical setting

Product and Immune Concerns

FDA has highlighted peptide aggregation, impurities, product characterization, and possible immune-reaction concerns.

Injection and Metabolic Risks

Injection can cause local reactions or infection. Possible metabolic effects and interactions with glucose-lowering drugs require study rather than assumptions of compatibility.

Individual Health History

Discuss medications, pregnancy or breastfeeding, and significant medical conditions with your provider. Limited data cannot establish safety for these groups.

Combining Treatments

Adding MOTS-c to other peptides or metabolic medications does not establish extra benefit. Combination safety and effective dosing remain uncertain.

Medication and Pharmacy Standards

Clear information about the product, evidence, and regulatory status belongs in every treatment discussion.

Research Review Is Not Approval

Compounding advisory review is separate from drug approval. A committee discussion or recommendation does not itself establish final list inclusion or availability.

Appropriate Sourcing

Any prescribing or compounding must satisfy current requirements. Pharmacy licensure and purity testing do not establish permission to compound an ingredient or prove clinical benefit.

Compounded medicines are not FDA-approved. This page does not promise a MOTS-c prescription or a future availability date.

Your Metabolic Health, in Context

If you are concerned about fatigue, weight, or blood glucose, begin with an evaluation of your symptoms and health history.

Understand the Full Picture

Review sleep, activity, nutrition, medications, and relevant medical conditions. Testing should be guided by your individual circumstances.

Plan an Appropriate Next Step

Our Pasadena team can discuss established care options, follow-up, and research questions without assuming an investigational peptide is the answer.

Doctor and patient reviewing metabolic health information on a tablet

Frequently Asked Questions

Practical answers about the research and your care options.

Person holding a question mark for frequently asked questions
Is MOTS-c FDA-approved?

No. MOTS-c remains investigational. Research registration or compounding review does not establish drug approval.

Does it improve diabetes or cause weight loss?

Clinical benefits are not established. Early experimental findings and a registered trial are not a substitute for completed human results.

Can it replace exercise?

No evidence establishes MOTS-c administration as a replacement for physical activity. Exercise-related changes in natural peptide levels answer a different scientific question.

Is there an established dose?

A validated clinical regimen is not established. A research protocol is not a self-treatment guide.

Can athletes use it?

MOTS-c is prohibited at all times under WADA rules. Athletes should consult their anti-doping organization before using any medication, peptide, or supplement.

Can it be combined with metabolic medications?

Interactions are not adequately characterized. Review all medications and supplements with your clinician; do not adjust prescribed treatment to add an investigational compound.

What side effects are known?

The full adverse-effect profile is incomplete. Product impurities, immune reactions, injection-related risks, and unintended metabolic effects are concerns.

What can I expect from a consultation?

A review of your concerns, health history, research questions, and appropriate care options. A consultation does not guarantee access to MOTS-c.

Take the Next Step for Your Metabolic Health

Meet with our medical team to discuss your concerns and build a personalized care plan.

Book Your Appointment

Important Information

MOTS-c is investigational and not FDA-approved. This page is educational and does not establish treatment availability or replace medical advice. Human benefits and long-term safety remain uncertain.